Biological medication for rheuma

RX_RHEUMA_BIOLOGICAL

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04AA24|L04AC03|L04AB04|L04AB01|L04AB06|L04AB02|L04AB05|L04AA26|L01XC02|L04AC10|L04AC07|L04AC05

3695

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

3552

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

3552

diagram downward connector

Include endpoints None

3552

diagram downward connector
RX_RHEUMA_BIOLOGICAL

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 3552 2196 1356
Unadjusted prevalence (%) 1.00 1.11 0.86
Mean age at first event (years) 46.81 46.45 47.40

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.34 [1.32, 4.14] 3.5e-3 63
15 years 0.01 1.60 [0.88, 2.90] 1.2e-1 43
5 years 0.00 1.63 [0.84, 3.17] 1.5e-1 13
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_RHEUMA_BIOLOGICAL – Biological medication for rheuma
GWS hits: 2

Survival analyses between endpoints

Plot

before Biological medication for rheuma
after Biological medication for rheuma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Biological medication for rheuma